TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$2.03M2017: $170.37M2018: -$75.52M2019: -$140.48M2020: $5.26M2021: -$119.03M2022: -$110.79M2023: -$56.03M2024: -$86.23M2025: -$75.59M-$75.59M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$75.59M+12.3%
2024-$86.23M-53.9%
2023-$56.03M+49.4%
2022-$110.79M+6.9%
2021-$119.03M-2363.4%
2020$5.26M+103.7%
2019-$140.48M-86.0%
2018-$75.52M-144.3%
2017$170.37M+8484.5%
2016-$2.03M—